Bioterrorism

  • Robert Partridge

Abstract

Biological terrorism is the intentional release of biological agents into the environment to cause disease or death in a population. The recent anthrax cases in the United States have demonstrated that bioterrorism is a real threat for civilian populations, and that emergency medicine is the first line of defense against any biological attack. Practitioners of emergency medicine need to be prepared for a bioterrorism event, equipped to identify and detect and event, as well as evaluate and treat persons who may have been exposed to biological agents. Emergency medicine practitioners should be familiar with the likely agents that might be used in a bioterrorism event.

Keywords

Tetracycline Chloramphenicol Encephalitis Doxycycline Clostridium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    CDC. Update: Investigation of Bioterrorism Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial TherapyGoogle Scholar
  2. 2.
    October, 2001. MMWR Weekly Report. 2001;50(42):909–919.Google Scholar
  3. 3.
    Inhalational Anthrax among Postal Workers in Washington, D.C., and New Jersey. The New York City Department of Health. Alert #5. October 25,2001.Google Scholar
  4. 4.
    Torok TJ, Tauxe RV, Wise RP, et al. A Large Community Outbreak of Salmonellosis Caused by Intentional Restaurant Salad Bars. JAMA. 1997;278(5):389–395.PubMedCrossRefGoogle Scholar
  5. 5.
    Meselson M, Guillemin J, Hanna P. Anthrax. N Engl J Med. 1999;341:815–826.PubMedCrossRefGoogle Scholar
  6. 6.
    Bush LM, Abrams BH, Beall A, Johnson CC. Index Case of Fatal Inhalational Anthrax Due to Bioterrorism in the United States. N Engl J Med. 2001;345(22):1607–1610.PubMedCrossRefGoogle Scholar
  7. 7.
    Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 2001;7(6):933–944.PubMedCrossRefGoogle Scholar
  8. 8.
    CDC. Notice to Readers: Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax. MMWR. 2001;50(44):984–986Google Scholar
  9. 9.
    Inglesby TV, Henderson DA, Bartlett JG et al. Anthrax as a Biological Weapon. JAMA 1999;281(18):1735–1745.PubMedCrossRefGoogle Scholar
  10. 10.
    Franz DR, Jahrling PB, Friedlander AM, Hoover DL, et.al. Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents. JAMA. 1997;278:399–411.PubMedCrossRefGoogle Scholar
  11. 11.
    Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. Biological Warfare, A Historical Perspective. JAMA. 1997;278:412–417.PubMedCrossRefGoogle Scholar
  12. 12.
    Macintyre AG, Christopher GW, Eitzen EM, Gum R, et.al. Weapons of Mass Destruction Events With Contaminated Casualties: Effective Planning for Health Care Facilities. JAMA. 2000;283:242–249.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Robert Partridge
    • 1
  1. 1.Department of Emergency MedicineBrown Medical School, Rhode Island HospitalProvidenceUSA

Personalised recommendations